Researchers discover a potential biomarker for AML relapse after stem cell transplant

Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to a study recently published in Blood Cancer Journal (2015; doi:10.1038/bcj.2015.58). There is …

[Read the full article here]

Comments are closed.